Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry

Neuroscience Letters

Volumn 485, Issue 1, 2010, Pages 49-54

  D'Aguanno, Simona ^a,b   Franciotta, Diego ^c   Lupisella, Santina ^a,b   Barassi, Alessandra ^d   Pieragostino, Damiana ^f,g   Lugaresi, Alessandra ^f,g   Centonze, Diego ^a,b   D'Eril, Gianlodovico Melzi ^d   Bernardini, Sergio ^b,e   Federici, Giorgio ^b,e   Urbani, Andrea ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f Centro Studi sull'Invecchiamento CeSI   (Italy)

^g UNIVERSITY OF CHIETI   (Italy)

Author keywords

Biomarkers; CSF; Guillain Barr syndrome; Oxidative damage; Protein carbonylation; Proteomics

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E; BETA2 GLYCOPROTEIN 1; COMPLEMENT COMPONENT C3; DIMER; GLYCOPHORIN A; IMMUNOGLOBULIN M; MONOMER; PREALBUMIN; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; CARBONYLATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLYCOSYLATION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOLOGY; ISOELECTRIC FOCUSING; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; GUILLAIN-BARRE SYNDROME; HUMANS; ISOELECTRIC FOCUSING; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77957241238     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.08.060     Document Type: Article

References (33)

1. Ang C.W., Jacobs B.C., Laman J.D. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol. 2004, 25:61-66.
2. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barrè syndrome. Ann. Neurol. 1990, 27:S21-S24.
3. Bai S., Liu S., Guo X., Qin Z., Wang B., Li X., Qin Y., Liu Y.H. Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients. Mol. Vis. 2009, 15:1638-1648.
4. Bruschi M., Musante L., Candiano G., Santucci L., Zennaro C., Carraro M., Del Boccio P., Gusmano R., Perfumo F., Urbani A., Ghiggheri G.M. Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves. Electrophoresis 2006, 27:2960-2969.
5. Candiano G., Musante L., Bruschi M., Petretto A., Santucci L., Del Boccio P., Pavone B., Perfumo F., Urbani A., Scolari F., Ghiggheri G.M. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J. Am. Soc. Nephrol. 2006, 11:3139-3148.
6. Chandan K., Jana C.H., Das N., Rajindar S., Sohal R.S. Specificity of age-related carbonylation of plasma proteins in the mouse and rat. Arch. Biochem. Biophys. 2002, 397:433-439.
7. Chang K.H., Lyu R.K., Tseng M.Y., Ro L.S., Wu Y.R., Chang H.S., Hsu W.C., Kuo H.C., Huang C.C., Chu C.C., Hsieh S.Y., Chen C.M. Elevated haptoglobin level of cerebrospinal fluid in Guillain-Barré syndrome revealed by proteomics analysis. Proteomics Clin. Appl. 2007, 1:467-475.
8. Chiang H.L., Lyu R.K., Tseng M.Y., Chang K.H., Chang H.S., Hsu W.C., Kuo H.C., Chu C.C., Wu Y.R., Ro L.S., Huang C.C., Chen C.M. Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders. Clin. Chim. Acta 2009, 405:143-147.
9. D'Aguanno S., Barassi A., Lupisella S., Melzi d'Eril G., Del Boccio P., Pieragostino D., Palloti F., Carelli V., Valentino M.L., Liguori R., Avoni P., Bernardini S., Gambi D., Urbani A., Federici G. Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis. J. Neuroimmunol. 2008, 193:156-160.
10. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., Colomco R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329:23-38.
11. Davidsson P., Westman-Brinkmalm A., Nilsson C.L., Lindbjer M., Paulson L., Andreasen N., Sjogren M., Blennow K. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport 2002, 13:611-615.
12. Di Martino S.J., Trujillo G., McVoy L.A., Zhang J., Kew R.R. Upregulation of vitamin D binding protein (Gc-globulin) binding sites during neutrophil activation from a latent reservoir in azurophil granules. Mol. Immunol. 2007, 44:2370-2377.
13. Duan W., Achen M.G., Richardson S.J., Lawrence M.C., Wettenhall R.E., Jaworowski A., Schreiber G. Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin. Implications for the evolution of structure and function of transthyretin in vertebrates. Eur. J. Biochem. 1991, 200:679-687.
14. Finehout E.J., Frank Z., Lee K.H. Towards two-dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual. Electrophoresis 2004, 25:2564-7255.
15. Flachenecker P. Epidemiology of neuroimmunological diseases. J. Neurol. 2006, 253:2-8.
16. Hadden R.D., Cornblath D.R., Hughes R.A., Zielasek J., Hartung H.P., Toyka K.V., Swan A.V. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma exchange/sandoglobulin Guillain-Barré syndrome Trial Group. Ann. Neurol. 1998, 44:780-788.
17. Hartung H.P., Pollard J.D., Harvey G.K., Toyka K.V. Immunopathogenesis and treatment of the Guillain-Barré syndrome, Part I. Muscle Nerve 1995, 18:137-153.
18. Himmelfarb J., McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 2001, 60:358-363.
19. Jin T., Hu L.S., Chang M., Wu J., Winblad B., Zhu J. Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Eur. J. Neurol. 2007, 14:563-568.
20. Langner C.A., Birkenmeier E.H., Roth K.A., Bronson R.T., Gordon J.I. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J. Biol. Chem. 1991, 266:11955-11964.
21. Lehmensiek V., Süssmuth S.D., Brettschneider J., Tauscher G., Felk S., Gillardon F., Tumani H. Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS). J. Neuroimmunol. 2007, 185:190-194.
22. Lenive R.L., Wehr N., Williams J.A., Stadtman E.R., Shacter E. Determination of carbonyl groups in oxidized proteins. Methods Mol. Biol. 2000, 99:15-24.
23. Liu X.D., Zeng B.F., Xu J.G., Zhu H.B., Xia O.C. Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation. Proteomics 2006, 6:1019-1028.
24. Mera K., Anraku M., Kitamura K., Nakajou K., Maruyama T., Tomita K., Otagiri M. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens. Res. 2005, 28:973-980.
25. Ranganathan S., Williams E., Ganchev P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Brown R.H., Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 2005, 95:1461-1471.
26. Serot J.M., Christmann D., Dubost T., Couturier M. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1997, 63:506-508.
27. Shacter E., Williams J.A., Lim M., Levine R.L. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic. Biol. Med. 1994, 17:429-437.
28. Stadtman E.R., Barlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab. Rev. 1998, 30:225-243.
29. Tedeschi A., Baratè C., Minola E., Morra E. Cryoglobulinemia. Blood Rev. 2007, 4:183-200.
30. Tu G.F., De Jong F., Apostolopoulos J., Nagashima M., Fidge N., Schreiber G., Howlett G. Effect of acute inflammation on rat apolipoprotein mRNA levels. Inflammation 1987, 11:241-251.
31. van Doorn P.A., Ruts L., Jacobs B.C. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 2008, 7:939-950.
32. Xiao F., Chen D., Lu Y., Xiao Z., Guan L.F., Yuan J., Wang L., Xi Z.Q., Wang X.F. Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy. Brain Res. 2009, 1255:180-189.
33. Yang Y.R., Liu S.L., Qin Z.Y., Liu F.J., Qin Y.J., Bai S.M., Chen Z.Y. Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome. Cell Mol. Neurobiol. 2008, 28:737-744.